Authors: JELLIFFE RW SCHUMITZKY A BAYARD D MILMAN M VANGUILDER M WANG X JIANG F BARBAUT X MAIRE P

Citation: Rw. Jelliffe et al., MODEL-BASED, GOAL-ORIENTED, INDIVIDUALIZED DRUG-THERAPY - LINKAGE OF POPULATION MODELING NEW MULTIPLE MODEL DOSAGE DESIGN, BAYESIAN FEEDBACK AND INDIVIDUALIZED TARGET GOALS, Clinical pharmacokinetics, 34(1), 1998, pp. 57-77

Authors: JELLIFFE R MILMAN M JIANG F SCHUMITZKY A WANG X BAYARD D VANGUILDER M

Citation: R. Jelliffe et al., MAXIMUM-ENTROPY (ME) DISCRETE POPULATION PK PARAMETER DISTRIBUTIONS FOR USE WITH MULTIPLE MODEL (MM) DOSAGE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 76-76

Authors: JELLIFFE RW BAYARD D SCHUMITZKY A MILMAN M VANGUILDER M

Citation: Rw. Jelliffe et al., PHARMACO-INFORMATICS - MORE PRECISE DRUG-THERAPY FROM MULTIPLE MODEL (MM) STOCHASTIC ADAPTIVE-CONTROL REGIMENS - EVALUATION WITH SIMULATED VANCOMYCIN THERAPY, Journal of the American Medical Informatics Association, 1994, pp. 972-972

Authors: SCHUMITZKY A JELLIFFE RW VANGUILDER M

Citation: A. Schumitzky et al., NPEM2 - A PROGRAM FOR PHARMACOKINETIC POPULATION ANALYSIS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 163-163

Authors: JELLIFFE RW SCHUMITZKY A VANGUILDER M LIU M HU L MAIRE P GOMIS P BARBAUT X TAHANI B

Citation: Rw. Jelliffe et al., INDIVIDUALIZING DRUG-DOSAGE REGIMENS - ROLES OF POPULATION PHARMACOKINETIC AND DYNAMIC-MODELS, BAYESIAN FITTING, AND ADAPTIVE-CONTROL, Therapeutic drug monitoring, 15(5), 1993, pp. 380-393